cediranib - CISMeF

Preferred Label : cediranib;

MeSH note : indole-ether quinazoline; highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer;

CISMeF synonym : AZD2171;

MeSH synonym : 4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline;

MeSH hyponym : AZD-2171; AZD 2171; 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline (2Z)-but-2-enedioate (1:1); 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline (2Z)-but-2-enedioate; AZD2171 maleate;

MeSH Related Number : 68AYS9A614;

Is substance : O;

UNII : NQU9IPY4K9;

InChIKey : XXJWYDDUDKYVKI-UHFFFAOYSA-N;

Details

Origin ID

C500926;

UMLS CUI

C1698364;

ATC code(s)
- cediranib [ATC Code]
Currated CISMeF NLP mapping
- Cediranib [NCIt concept]
MeSH term(s) associated for indexing
- indoles [MeSH Descriptor]
- quinazolines [MeSH Descriptor]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- protein kinase inhibitors [MeSH Descriptor]
Record concept(s)
- AZD-2171 maleate [MeSH concept]
- AZD2171 [MeSH concept]
- Recentin [MeSH concept]
- cediranib [MeSH concept]
- cediranib maleate [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cediranib [NCIt concept]
- cediranib [ATC Code]
Validated automatic mappings to BTNT
- Cediranib Maleate [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients